M&A news

LTS Lohmann Therapie-Systeme AG Acquires Renaissance Lakewood, LLC

Renaissance Lakewood, LLC acquired by LTS Lohmann Therapie-Systeme AG

AcquisitionPharmaceuticals

Get the full Renaissance Lakewood, LLC company profile

Access contacts, investors, buying signals & more

Open in Dashboard
Renaissance Lakewood, LLC logo
Acquired

Renaissance Lakewood, LLC

Pharmaceutical Manufacturing

Undisclosed amount

October 13, 2025

LTS Lohmann Therapie-Systeme AG logo
Acquirer

LTS Lohmann Therapie-Systeme AG

Pharmaceutical Manufacturing

LTS Lohmann Therapie-Systeme AG has acquired Renaissance Lakewood, LLC for an undisclosed amount. The acquisition sees the Germany-based drug delivery systems specialist take ownership of Renaissance, a US-based contract development and manufacturing organization (CDMO) with extensive expertise in nasal sprays and sterile injectable dosage forms for pharmaceutical and biotech companies.

Renaissance Lakewood, LLC operates as a pure-play CDMO, providing comprehensive services from early-stage development through commercial launch. With over two decades of experience, the company offers aseptic fill-finish development and manufacturing for vials, alongside unit-dose, bi-dose, and multi-dose nasal spray manufacturing capabilities. Its services also encompass analytical development, spray characterization, and formulation optimization, supporting a broad range of products including DEA Schedule I-V substances. Renaissance is recognized for its "bench-to-shelf" service offering.

This strategic acquisition is expected to significantly enhance LTS's capabilities and market presence in advanced drug delivery systems. By integrating Renaissance's specialized manufacturing and development expertise, LTS aims to expand its offering in high-demand areas like sterile injectables and complex nasal spray products. The move provides LTS with established US-based manufacturing facilities and a proven track record, strengthening its ability to support pharmaceutical clients globally with a broader range of CDMO services.

The synergy between LTS's existing focus on drug delivery and Renaissance's robust CDMO operations is anticipated to create a more comprehensive service provider. The combined entity will leverage Renaissance’s advanced laboratory support and quality systems to deliver integrated solutions across the pharmaceutical development lifecycle. This acquisition positions LTS to capitalize on growing demand for specialized contract manufacturing and further solidify its standing in the competitive drug delivery and pharmaceutical services market.

Buying signals & intent

Our AI suggests Renaissance Lakewood, LLC may be interested in:

Pharmaceutical Ingredients
Packaging Solutions
Quality Assurance Services
Regulatory Compliance
Laboratory Testing

Unlock GTM signals

Discover Renaissance Lakewood, LLC's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at Renaissance Lakewood, LLC.

Unlock decision-makers